Time to redefine Myeloma
Guy Pratt(Heart of England NHS Foundation Trust), Jenny Bird, John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), Gordon Cook(St James's University Hospital), Matthew Streetly(St Thomas' Hospital), Roger G. Owen(Leeds General Infirmary), Kwee Yong(London Cancer), Ashutosh Wechalekar(Boston University), Andrew Chantry(University of Sheffield), Karthik Ramasamy(Oxford University Hospitals NHS Trust), Nicola Mulholland(King's College Hospital), Graham Jackson(University of Newcastle Australia), Stella Bowcock(King's College Hospital), Maggie Lai(Myeloma UK), Eric Low(RED Consulting (Norway)), Neil Rabin(University College London)
Cited by 17
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k
Systemic amyloidosis
|The Lancet|2015|984
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750